Apogee Therapeutics, Inc. - COMMON STOCK (APGE)
CUSIP: 03770N101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 61,257,262
- Total 13F shares
- 56,092,373
- Share change
- +1,706,867
- Total reported value
- $3,292,239,932
- Put/Call ratio
- 578%
- Price per share
- $58.74
- Number of holders
- 137
- Value change
- +$134,148,823
- Number of buys
- 70
- Number of sells
- 71
Quarterly Holders Quick Answers
What is CUSIP 03770N101?
CUSIP 03770N101 identifies APGE - Apogee Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03770N101:
Top shareholders of APGE - Apogee Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VR Adviser, LLC |
13F
|
Company |
14%
|
8,493,321
|
$334,212,181 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
12%
|
7,505,875
|
$295,356,182 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.8%
|
3,546,949
|
$139,572,444 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
2,742,549
|
$107,919,304 | — | 30 Jun 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
4.4%
|
2,712,096
|
$106,720,978 | — | 30 Jun 2024 | |
| BRAIDWELL LP |
13F
|
Company |
3.9%
|
2,392,042
|
$94,126,853 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.5%
|
2,117,870
|
$83,338,185 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.4%
|
2,105,636
|
$82,856,776 | — | 30 Jun 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3.3%
|
2,048,647
|
$80,614,259 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
1,970,320
|
$77,532,092 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.2%
|
1,961,863
|
$77,199,309 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
1,561,362
|
$61,439,595 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.8%
|
1,132,270
|
$44,554,825 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
1,005,470
|
$39,565,244 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
1.6%
|
1,000,000
|
$39,350,000 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.4%
|
836,283
|
$32,907,736 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
768,221
|
$30,230,000 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.2%
|
746,159
|
$29,361,357 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
740,861
|
$29,157,818 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.8%
|
487,000
|
$19,163,450 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.62%
|
379,130
|
$14,918,766 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.57%
|
349,556
|
$13,755,028 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
337,153
|
$13,266,970 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.54%
|
330,000
|
$12,985,500 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.54%
|
329,000
|
$12,946,150 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.52%
|
318,327
|
$12,526,167 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
311,203
|
$12,245,838 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.5%
|
306,078
|
$12,044,170 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.49%
|
302,222
|
$11,892,436 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.47%
|
290,000
|
$11,411,500 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.44%
|
269,232
|
$10,594,292 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.41%
|
250,000
|
$9,837,500 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
238,742
|
$9,394,498 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
234,780
|
$9,238,618 | — | 30 Jun 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.29%
|
180,077
|
$7,086,030 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
174,814
|
$6,878,931 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.26%
|
156,266
|
$6,149,068 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
156,204
|
$6,146,627 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.25%
|
150,135
|
$5,907,795 | — | 30 Jun 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.24%
|
147,472
|
$5,803,023 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
137,898
|
$5,426,287 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
135,747
|
$5,341,645 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
116,318
|
$4,577,113 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.18%
|
112,858
|
$4,440,962 | — | 30 Jun 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.18%
|
109,410
|
$4,305,284 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
100,000
|
$3,935,000 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
97,065
|
$3,819,508 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
95,006
|
$3,738,486 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.15%
|
90,000
|
$3,541,335 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.14%
|
87,201
|
$3,431,359 | — | 30 Jun 2024 |
Institutional Holders of Apogee Therapeutics, Inc. - COMMON STOCK (APGE) as of Q3 2024
As of 30 Sep 2024,
Apogee Therapeutics, Inc. - COMMON STOCK (APGE) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,092,373 shares.
The largest 10 holders included
VR Adviser, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., RTW INVESTMENTS, LP, Driehaus Capital Management LLC, VANGUARD GROUP INC, Fairmount Funds Management LLC, PERCEPTIVE ADVISORS LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
137
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
137
Q3 2024 holders
137
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.